Save
Protocolo de atención del Ataque Cerebrovascular Agudo y Unidad de ACV agudo
World Stroke Academy, Sheila Martins, 198959
Managing a stroke unit in a rural African setting
World Stroke Academy, Alan Bryer, 193083
How to manage hypertension in the acute phase?
World Stroke Academy, Natan Bornstein, 199291
GENERAL OR LOCAL ANESTHESIA IN INTRA ARTERIAL THERAPY (”GOLIATH”): A RANDOMIZED TRIAL
World Stroke Academy, Claus Simonsen, 183417
THE ANSTROKE TRIAL
World Stroke Academy, Pia Hendén, 183412
PRASUGREL VERSUS CLOPIDOGREL IN ISCHEMIC STROKE PATIENTS: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP TRIAL (THE PRASTRO-I)
World Stroke Academy, Kazunori Toyoda, 183419
MILD STROKE DUE TO LARGE ARTERY OCCLUSION. WHEN IS IV THROMBOLYSIS NOT ENOUGH? RESULTS FROM THE SITS-ISTR REGISTRY
World Stroke Academy, Michael Mazya, 183415
LONG-TERM ANTITHROMBOTIC TREATMENT IN INTRACRANIAL HEMORRHAGE SURVIVORS WITH ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS
World Stroke Academy, Eleni Korompoki, 183413
RESUMPTION OF ORAL ANTICOAGULATION AFTER INTRACEREBRAL HEMORRHAGE IS ASSOCIATED WITH DECREASED MORTALITY AND FAVORABLE FUNCTIONAL OUTCOME
World Stroke Academy, Joji Kuramatsu, 183414
Early Prolonged Ambulatory Cardiac Monitoring in Stroke (EPACS): Randomised Clinical Trial using patch-based cardiac monitoring
World Stroke Academy, James Teo, 183418
COMPARING THE IMPACT OF BASELINE COLLATERAL STATUS ASSESSED BY DIFFERENT COLLATERAL SCORES AND IMAGING MODALITIES ON OUTCOMES IN ACUTE ISCHEMIC PATIENTS: META-ANALYSIS FROM THE HERMES-COLLABORATION
World Stroke Academy, Henrik Gensicke, 183411
RISK FACTORS FOR DELIRIUM AND COGNITIVE IMPAIRMENT AFTER STROKE
World Stroke Academy, Sarah Pendlebury, 183406
ROLE OF AMYLOID IMAGING IN POST-STROKE MCI AND DEMENTIA
World Stroke Academy, Vincent CT Mok, 183405
CAA-RELATED COGNITIVE IMPAIRMENT: CLINICAL FEATURES AND MECHANISMS
World Stroke Academy, David J Werring, 183408
THE NEUROBIOLOGY OF VASCULAR DEMENTIA
World Stroke Academy, Costantino Iadecola , 183404
CHOLESTEROL: HOW LOW SHOULD WE GO, AND HOW?
World Stroke Academy, George Ntaios, 183400
ANTI-PLATELET DRUGS: WHY DO WE STILL USE ASPIRIN?
World Stroke Academy, Ale Algra, 183398
AIR POLLUTION AND RISK OF STROKE
World Stroke Academy, Valery Feigin, 183392
THE STROKE ROAD MAP
World Stroke Academy, M. Patrice Lindsay, 183393
LESSONS FROM INTERSTROKE
World Stroke Academy, Martin O’Donnell, 183395
STROKE AND POVERTY
World Stroke Academy, Bo Norrving, 183394
HOW TO ORGANIZE YOUR STROKE CENTER AND STROKE NETWORK
World Stroke Academy, Mayank Goyal, 183386
ENDOVASCULAR STROKE TREATMENT BEYOND GUIDELINES: A PLEA FOR THE PATIENT
World Stroke Academy, Jan Gralla, 183387
PRE-HOSPITAL SELECTION FOR ENDOVASCULAR TREATMENT
World Stroke Academy, Urs Fischer, 183385
ENDOVASCULAR TREATMENT OF ISCHEMIC STROKE: CURRENT EVIDENCE
World Stroke Academy, Pooja Khatri, 183388
OFF LABEL USE OF ALTEPLASE FOR ACUTE ISCHEMIC STROKE (AIS) IN PATIENTS OVER 80 YEARS OF AGE: INDIVIDUAL-PATIENT-DATA META-ANALYSIS OF EIGHT TRIALS
World Stroke Academy, Werner Hacke, 183377
TESPI(THROMBOLYSIS IN ELDERLY STROKE PATIENTS IN ITALY): RANDOMIZED CONTROLLED TRIAL OF ALTEPLASE VERSUS STANDARD TREATMENT IN PATIENTS AGED >80 YEARS WITHIN 3HRS AFTER STROKE ONSET
World Stroke Academy, Svetlana Lorenzano, 183380
PROGNOSTIC AND TREATMENT IMPACT OF PENUMBRAL IMAGING IN POOLED ANALYSIS OF RANDOMIZED TRIALS OF ENDOVASCULAR STENT THROMBECTOMY
World Stroke Academy, Bruce Campbell, 183374
TALOS: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO TEST THE VASCULAR AND NEUROPROTECTIVE EFFECTS OF CITALOPRAM IN PATIENTS WITH ACUTE ISCHEMIC STROKE
World Stroke Academy, Kristian Lundsgaard Kraglund, 183379
THROMBOLYSIS OR ANTICOAGULATION FOR CEREBRAL VENOUS THROMBOSIS (TO-ACT): A RANDOMISED CONTROLLED TRIAL
World Stroke Academy, Jonathan Coutinho, 183375
THE NORWEGIAN TENECTEPLASE STROKE TRIAL (NOR-TEST): RANDOMISED CONTROLLED TRIAL OF TENECTEPLASE VS. ALTEPLASE IN ACUTE ISCHAEMIC STROKE
World Stroke Academy, Nicola Logallo, 183367
CONTACT ASPIRATION VERSUS STENT RETRIEVER FRONT- LINE FOR RECANALISATION IN ACUTE CEREBRAL INFARCTION: THE ASTER TRIAL
World Stroke Academy, Bertrand Lapergue, 183365
THE T3 TRIAL: TRIAGE, TREATMENT AND TRANSFER OF PATIENTS WITH STROKE IN EMERGENCY DEPARTMENTS
World Stroke Academy, Sandy Middleton, 183369
EFFICACY OF EARLY COGNITIVE-LINGUISTIC TREATMENT FOR APHASIA DUE TO STROKE; A RANDOMISED CONTROLLED TRIAL (RATS-3)
World Stroke Academy, Femke Nouwens, 183371
DAWN in full daylight (DWI or CTP Assessment with Clinical Mismatch in the Triage of Wake Up and Late Presenting Strokes Undergoing Neurointervention)
World Stroke Academy, Raul Nogueira, 183370
PFO Closure in the Gore REDUCE Clinical Trial: Primary Results
World Stroke Academy, Scott E. Kasner, 183364
CLOSURE OF PATENT FORAMEN OVALE, ORAL ANTICOAGULANTS OR ANTIPLATELET THERAPY TO PREVENT STROKE RECURRENCE (CLOSE): A RANDOMIZED CLINICAL TRIAL
World Stroke Academy, Jean-Louis Mas, 183368
Official Welcome & Large Clinical Trials: Convenor
World Stroke Academy, Robert Mikulik, 183363
Official Welcome & Large Clinical Trials: Convenor
World Stroke Academy, Martin Dichgans, 183362
Assessment & Evaluation
World Stroke Academy, Julian Boesel, 188672
Intubation and artificial ventilation in acute stroke – when is it needed?
World Stroke Academy, Julian Boesel, 182301
What to do when I find resistant bacteria on my ward?
World Stroke Academy, Achim Kaasch, 182302
Main neuropathological features
World Stroke Academy, Kurt Jellinger, 170314
When is multimodal imaging necessary?
World Stroke Academy, Jens Fiehler, 170247
Neurosonology and Pharmacology
World Stroke Academy, Laszlo Csiba, 166166
Management of TIA
World Stroke Academy, Peter Sandercock, 154838
Investigation of TIA
World Stroke Academy, Peter Sandercock, 154837
Clinical Assessment of TIA
World Stroke Academy, Peter Sandercock, 154836
TIA
World Stroke Academy, Peter Sandercock, 150371
Why are TIAs important
World Stroke Academy, Peter Sandercock, 150372
Evaluation
World Stroke Academy, Peter Sandercock, 184709
PRO - WE SHOULD OPERATE ON MORE PATIENTS
World Stroke Academy, Girish Menon, 154555
CON - THE POLYPILL IS ENOUGH
World Stroke Academy, Jayanta Roy, 154554
PRO - PREVENTION MUST BE TARGETED
World Stroke Academy, Hans Christoph Diener, 154553
USING GENETICS TO PREDICT STROKE RISK: IS IT USEFUL NOW AND WILL IT BE IN THE FUTURE?
World Stroke Academy, Sudha Seshadri, 154552
IS GENETICS IMPORTANT FOR STROKE IN AFRICA?
World Stroke Academy, Rufus Akinyemi, 154551
INTRACEREBRAL HAEMORRHAGE: WHAT DO RECENT GENETIC STUDIES TELL THE PRACTICING CLINICIAN?
World Stroke Academy, Sudha Seshadri, 154550
TELESTROKE IN INDIA
World Stroke Academy, Madakasira Vasantha Padma, 154548
TELESTROKE IN DEVELOPING COUNTRIES
World Stroke Academy, Sombat Muengtaweepongsa, 154547
THE TELESTROKE UNIT CONCEPT: MAKING EVIDENCE BASED STROKE MANAGEMENT AVAILABLE IN UNDERSERVED AREAS WORLDWIDE?
World Stroke Academy, Heinrich Audebert, 154546
HYPERTENSION IN STROKE IN ASIA
World Stroke Academy, Jong S. Kim, 154545
BP MANAGEMENT IN THE ACUTE STROKE
World Stroke Academy, Craig Anderson, 154544
GLOBAL BURDEN OF STROKE: HYPERTENSION AT THE CORE
World Stroke Academy, Daniel Lackland, 154543
WHAT WILL THE NEXT BIG ADVANCE BE?
World Stroke Academy, Werner Hacke, 154538
PHARMACOLOGICAL APPROACHES OF EMOTIONAL AND BEHAVIORAL DISORDERS AFTER STROKE
World Stroke Academy, Jong S. Kim, 154542
INTRA CEREBRAL HAEMORRHAGES: CAN WE STOP THEM BLEEDING?
World Stroke Academy, Andrew M. Demchuk, 154537
RELATIONSHIP BETWEEN POST STROKE FATIGUE AND DEPRESSION
World Stroke Academy, M. Patrice Lindsay, 154541
THROMBOLYSIS: CAN WE DO BETTER?
World Stroke Academy, Stephen M. Davis, 154536
EMOTIONALISM AFTER STROKE
World Stroke Academy, Maree Hackett, 154540
ENDOVASCULAR THERAPY: WHERE TO NOW?
World Stroke Academy, Colin Derdeyn, 154535
PRE HOSPITAL MANAGEMENT: THE NEW FRONTIER
World Stroke Academy, Stephen M. Davis, 154534
DEPRESSION AFTER STROKE
World Stroke Academy, Maree Hackett, 154539
EMBEDDING EVIDENCE IN CLINICAL CARE
World Stroke Academy, Marion Walker, 154533
HIGH TECH: PERFUSION IMAGING IN ACUTE STROKE DECISION MAKING
World Stroke Academy, Bruce Campbell, 154526
TRIAGE AND PREHOSPITAL CARE WITH STEMO
World Stroke Academy, Martin Ebinger, 154530
HIGH TECH: IMMEDIATE MRI-BASED DECISION MAKING
World Stroke Academy, Niels Hjort, 154525
LIMITATIONS OF AMBULANCE-BASED TELEMEDICINE
World Stroke Academy, Heinrich Audebert, 154529
REAL WORLD: CT ANGIOGRAPGHY IN TIA AND ACUTE STROKE
World Stroke Academy, Bijoy Menon, 154524
USE OF TECHNOLOGY AND INTERNET FOR THROMBOLYTIC TREATMENT IN ASIA
World Stroke Academy, Ka Sing Lawrence Wong, 154528
ACUTE STROKE IMAGING -THE IDEAL IN RESOURCE LIMITED SETTINGS
World Stroke Academy, Dheeraj Khurana, 154523
SYSTEMS FOR TRIAGE AND PREHOSPITAL CARE IN THE DEVELOPING COUNTRIES
World Stroke Academy, Kameshwar Prasad, 154527
Stroke Medicine - Not only Ischemia, and more than just neurology
World Stroke Academy, Walter Johnson, 154835
Mapping Stroke Services: Can the resources-to-needs gap be closed?
World Stroke Academy, M. Patrice Lindsay, 154834
Stroke policies at WHO - Priorities and actions
World Stroke Academy, Cherian Varghese, 154833
Introduction: Stroke prevention from a public health perspective
World Stroke Academy, Jarnail Thakur, 154831
METABOLIC CHALLENGE AND MRI: A NEW APPROACH TO IMAGING THE PENUMBRA
World Stroke Academy, I Mhairi Macrae, 154522
PERICYTES: A NOVEL TARGET FOR STROKE THERAPY
World Stroke Academy, Brad Sutherland, 154521
STEM CELL DERIVED NEURONS: A NEW TOOL TO EXPLORE HUMAN STROKE BIOLOGY
World Stroke Academy, David Howells, 154520
TRANSLATIONAL STROKE BIOLOGY: PAST PRESENT AND FUTURE
World Stroke Academy, Malcolm R Macleod, 154519
ACHIEVING CONTROL OF HYPERTENSION
World Stroke Academy, Jong S. Kim, 154516
ATRIAL FIBRILLATION: IMPROVED DIAGNOSIS, AND IMPACT OF NEW ORAL ANTICOAGULANTS
World Stroke Academy, Hans Christoph Diener, 154515
LIFESTYLE, LIPID LOWERING DRUGS AND NUTRITION IN STROKE PREVENTION
World Stroke Academy, J. David Spence, 154514
CHALLENGES IN STROKE PREVENTION
World Stroke Academy, Ralph L. Sacco, 154513
SAH, DELAYED ISCHAEMIC DEFICITSAND VASOSPASM
World Stroke Academy, Gabriel Rinkel, 154510
WHAT TO DO IF A PATIENT ON ANTITHROMBOTICS DEVELOPS INTRACRANIAL BLEEDING
World Stroke Academy, Thorsten Steiner, 154509
HOW TO PREVENT INTRA CEREBRAL HAEMORRHAGE EXPANSION?
World Stroke Academy, Dar Dowlatshahi, 154508
GLOBAL BURDEN OF ICH
World Stroke Academy, Rohit Bhatia, 154507
Cryptogenic stroke
World Stroke Academy, Vincent Thijs, 150365
Cryptogenic Stroke Case Study and Author Interview with V. Thijs
World Stroke Academy, Vincent Thijs, 150366
Introduction
World Stroke Academy, Anthony Ward, 147085